Skip to main content
eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS: EFTR · Delayed Price · USD
0.0460
-0.0005 (-1.08%)
Jul 26, 2024, 3:52 PM EDT - Market closed

eFFECTOR Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Revenue
--3.551.4342-
Revenue Growth (YoY)
--148.46%-96.60%--
Cost of Revenue
21.6222.9223.3119.9621.8323.89
Gross Profit
-21.62-22.92-19.76-18.5320.17-23.89
Selling, General & Admin
11.0910.9312.6413.374.354.72
Operating Expenses
11.0910.9312.6413.374.354.72
Operating Income
-32.7-33.84-32.4-31.915.82-28.61
Interest Expense
-2.98-2.92-2.25-1.76-1.33-1.38
Interest & Investment Income
1.070.970.440.010.070.24
Other Non Operating Income (Expenses)
-0.02-0.03-0.571.040.010.01
EBT Excluding Unusual Items
-34.64-35.82-34.79-32.6214.56-29.74
Other Unusual Items
0.010.0112.1248.42-15.53
Pretax Income
-34.63-35.81-22.6715.814.56-14.21
Income Tax Expense
----0.35-
Earnings From Continuing Operations
-34.63-35.81-22.6715.814.21-14.21
Minority Interest in Earnings
-----14.05-
Net Income
-34.63-35.81-22.6715.80.17-14.21
Net Income to Common
-34.63-35.81-22.6715.80.17-14.21
Net Income Growth
---9416.87%--
Shares Outstanding (Basic)
322100
Shares Outstanding (Diluted)
322100
Shares Change (YoY)
68.04%32.77%14.37%1256.16%122.00%-
EPS (Basic)
-12.42-16.37-13.7626.152.94-297.06
EPS (Diluted)
-12.42-16.37-13.7611.002.82-297.06
EPS Growth
---290.68%--
Free Cash Flow
-29.28-29.65-26.09-24.9313.68-27.6
Free Cash Flow Per Share
-10.50-13.56-15.84-17.31128.83-577.03
Gross Margin
----48.02%-
Operating Margin
---911.99%-2230.56%37.66%-
Profit Margin
---1104.76%0.40%-
Free Cash Flow Margin
---734.34%-1743.36%32.57%-
EBITDA
-32.59-33.73-32.35-31.8715.98-28.3
EBITDA Margin
----38.05%-
D&A For EBITDA
0.110.110.050.020.160.31
EBIT
-32.7-33.84-32.4-31.915.82-28.61
EBIT Margin
----37.66%-
Effective Tax Rate
----2.41%-
Revenue as Reported
----42-
Source: S&P Capital IQ. Standard template.